Attovia Therapeutics, Inc.

NASDAQ:ATTO

Biotechnology

Healthcare
$15.53 -1.20%

-$0.18 today

Market cap
$709.92M
Beta
0.00
P/E (TTM)
-15.9
EPS (TTM)
-$0.86
52W Low $14.23High $28.00

Volume 0.34M

Average 0.45M

ATTO Common Stock

The par or stated value of issued common shares, plus paid-in capital where reported together.

Attovia Therapeutics, Inc.NASDAQ: ATTO

Common Stock · Q2 FY2026 · quarter ended Jun 2026

Common stock of $1K in Q2 FY2026

Q2 FY2026 common stock was $1K.

Context

  • Common stock amounted to 0.0% of total assets at the end of Q2 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
$1K-75.0% QoQ
Last fiscal yearDec 2025
$1K+0.0% YoY
Common Stock past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+0.0%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock history

USD · from the balance sheet

Latest · FY2025
1K USD
Year-over-year change
+0.0%
1-year CAGR
+0.0%

Common Stock vs competitors

How ATTO compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
  • Common stock amounts to 0.0% of total assets for ATTO, versus a peer median of 0.0%.
ATTO Competitors
Common Stock for ATTO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
AGMBAgomAb Therapeutics N.V. American Depositary SharesSep 2025€223.07M EUR——134.7%
ORKAOruka Therapeutics, Inc.Sep 2026$67K USD+39.6%+51.8%0.0%
ANABAnaptysBio, Inc.Mar 2026$29K USD-3.3%-1.2%0.0%
ALMSAlumis Inc. Common StockJun 2026$12K USD+20.0%+108.0%0.0%
CNTBConnect Biopharma Holdings LimitedDec 2025$10K USD+0.0%+0.0%0.0%
ZURAZura Bio LimitedMar 2026$9K USD+28.6%—0.0%
MLTXMoonLake ImmunotherapeuticsMar 2026$7K USD+16.7%+9.9%0.0%
EVMNEvommune, Inc.Mar 2026$4K USD+300.0%—0.0%
QTTBQ32 Bio Inc.Mar 2026$2K USD+0.0%-30.7%0.0%
ATTOAttovia Therapeutics, Inc.Jun 2026$1K USD——0.0%
ACRSAclaris Therapeutics, Inc.Mar 2026$1K USD+0.0%+0.0%0.0%
Peer median (excluding ATTO) —+16.7%+0.0%0.0%

Competitors are the stored peer set for ATTO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Attovia Therapeutics, Inc.

NASDAQ:ATTO

Intrinsic Alpha fair value

Locked

Current Price

$15.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.